Search

Your search keyword '"BIOLOGICAL MARKERS"' showing total 1,580 results

Search Constraints

Start Over You searched for: Descriptor "BIOLOGICAL MARKERS" Remove constraint Descriptor: "BIOLOGICAL MARKERS" Database Academic Search Index Remove constraint Database: Academic Search Index
1,580 results on '"BIOLOGICAL MARKERS"'

Search Results

1. Racial and socioeconomic disparities in non–small cell lung cancer molecular diagnostics uptake.

2. Increased expression of plasma mir-9-3p and let-7b-3p in methamphetamine use disorder and its clinical significance.

3. Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.

4. Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot–Marie–Tooth disease.

5. Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline.

6. Clinical and Biological Markers of Frailty Syndrome in Patients Undergoing Elective Percutaneous Coronary Intervention.

7. Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.

8. Association between metabolomics-based biomarker scores and 10-year cognitive decline in men and women. The Doetinchem Cohort Study.

9. Clinical biomarker–based biological ageing and the risk of adverse outcomes in patients with chronic kidney disease.

10. Plasma biomarkers in chronic single moderate–severe traumatic brain injury.

11. Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study.

12. Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.

13. Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum.

14. β2-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma.

15. The diagnostic value of pleural effusion/serum ratio of carcinoembryonic antigen and pleural effusion/serum ratio of interferon-γ in classification of pleural effusion.

16. Telomere length and 4-year changes in cognitive function in an older Mediterranean population at high risk of cardiovascular disease.

17. A pharmacometric multistate model for predicting long-term treatment outcomes of patients with pulmonary TB.

18. Comparison of human hair cortisol concentration stability for 1‐year and 2‐year test–retest intervals.

19. Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease.

20. Increases in amyloid-β42 slow cognitive and clinical decline in Alzheimer's disease trials.

21. Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy.

22. A Novel Four‑Gene Biomarker for Tobacco Smoking-Induced Colorectal Cancer Progression.

23. Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study.

24. Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).

25. Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage.

26. DNA variants detected in primary and metastatic lung adenocarcinoma: a case report and review of the literature.

27. Noninvasive biomarkers for lupus nephritis.

28. Evaluation of some nonroutine cardiac biomarkers among adults and children with beta-thalassemia major.

29. Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial.

30. Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.

31. Using Physiological Biomarkers to Optimize Management of TBI in Austere Environments.

32. Noninvasive Monitoring of Changes in Cerebral Hemodynamics During Prolonged Field Care for Hemorrhagic Shock and Hypoxia-Induced Injuries With Portable Diffuse Optical Sensors.

33. Characterizing the Asthma Phenotype of Military Personnel.

34. Accuracy of acute hyperglycemia as a biomarker of severe brain damage in children with traumatic brain injury.

35. Risk variables of heart failure among patients in China: grey relational approach based multi-dimensional assessment study.

36. Cognitive, Neuropsychological and Biological Effects of Oxygen–Ozone Therapy on Frailty: A Study Protocol for a 5-Week, Randomized, Placebo-Controlled Trial.

37. Pharmacogenomic Clinical Support Tools for the Treatment of Depression.

38. Oxidative Stress Markers in Multiple Sclerosis.

39. Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome.

40. Biomarkers of Waterpipe Tobacco Smoke Exposure: A Systematic Review and Meta-Analysis.

41. Remote Carbon Monoxide Capture via REDCap: Evaluation of an Integrated Mobile Application.

42. Diagnostic Accuracy of Point-of-Care Testing of C-Reactive Protein, Interleukin-6, and Procalcitonin in Neonates with Clinically Suspected Sepsis: A Prospective Observational Study.

43. A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.

44. PTCH1 mutation as a potential predictive biomarker for immune checkpoint inhibitors in gastrointestinal cancer.

45. Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.

46. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles.

47. Impact of increased protein intake in older adults: a 12-week double-blind randomised controlled trial.

48. Biomarker signatures associated with ageing free of major chronic diseases: results from a population-based sample of the EPIC-Potsdam cohort.

49. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.

50. Sixty years of conjecture over a urinary biomarker: a step closer to understanding the proposed link between anxiety and urinary pyrroles.

Catalog

Books, media, physical & digital resources